Cancer Chemoprevention by Targeting Proteasomal Degradation

Clinical Cancer Research

Volumn 10, Issue 7, 2004, Pages 2220-2221

  Yang, Chung S ^a   Chin, Khew Voon ^b   Lambert, Joshua D ^b  

^a RUTGERS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 3,12 DIOXOOLEANA 1,9 DIEN 28 OIC ACID; BORTEZOMIB; CYCLIN D1; CYCLIN E; CYCLINE; EPIGALLOCATECHIN GALLATE; FENRETINIDE; INDOMETACIN; OLEANOLIC ACID DERIVATIVE; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN BAX; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; RETINOIC ACID; RO 24 5531; ROSIGLITAZONE; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CANCER RESISTANCE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL GROWTH; CELL TRANSFORMATION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; NOTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

ANTICARCINOGENIC AGENTS; CYCLIN D1; CYCLIN E; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, RETINOIC ACID; RETINOBLASTOMA PROTEIN; UBIQUITIN;

EID: 1842583732     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0416     Document Type: Note

References (12)

1. Swanton C. Cell-cycle targeted therapies. Lancet Oncol 2004;5: 27-36.
2. Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther 1:226-31.
3. 1 cyclins: implications for combination therapy. Clin Cancer Res 2004;10:2570-7.
4. Langenfeld J, Lonardo F, Kiyokawa H, et al. Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation. Oncogene 1996;13: 1983-90.
5. Langenfeld J, Kiyokawa H, Sekula D, Boyle J, Dmitrovsky E. Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Proc Natl Acad Sci USA 1997;94:12070-4.
6. Boyle JO, Langenfeld J, Lonardo F, et al. Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. J Natl Cancer Inst (Bethesda) 1999;91:373-9.
7. Kitareewan S, Pitha-Rowe I, Sekula D, et al. UBEIL is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia. Proc Natl Acad Sci USA 2002;99: 3806-11.
8. Lapillonne H, Konopleva M, Tsao T, et al. Activation of peroxisome proliferator-activated receptor γ by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Cancer Res 2003;63: 5926-39.
9. Schwartz DC, Hochstrasser M. A superfamily of protein tags: ubiquitin, SUMO and related modifiers. Trends Biochem Sci 2003;28: 321-8.
10. Qiao D, Gaitonde SV, Qi W, Martinez JD. Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation. Carcinogenesis (Lond) 2001;22:957-64.
11. Adams J. Potential for proteasome inhibition in the treatment of cancer. Drug Discov Today 2003;8:307-15.
12. Nam S, Smith DM, Dou QP. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 2001;276:13322-30.